Proteina Co., Ltd. (KOSDAQ:468530)
South Korea · Delayed Price · Currency is KRW 17,120
+1,820 (11.90%)
Aug 29, 2025, 12:40 PM KST
Proteina Company Description
Proteina Co.,Ltd. develops protein-protein interaction profiling technology.
The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance.
It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information.
Proteina Co., Ltd. was founded in 2015 and is based in Seoul, South Korea.
Proteina Co., Ltd.
| Country | South Korea |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Tae-Young Yoon |
Contact Details
Address: Ace Techno Tower 8 #1301 Seoul, 08380 South Korea | |
| Phone | 82 2 6959 9309 |
| Website | proteina.co.kr |
Stock Details
| Ticker Symbol | 468530 |
| Exchange | KOSDAQ |
| Reporting Currency | KRW |
| ISIN Number | KR7468530001 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Tae-Young Yoon | Chief Executive Officer |
| Dai Seung Lee | Chief Financial Officer |
| Steve Hwang | Head of Investor Relations |